Anticoagulation Medications, Monitoring, and Outcomes in Patients with Cardiogenic Shock Requiring Temporary Mechanical Circulatory Support

This publication has 118 references indexed in Scilit:

• Escalation strategies, management, and outcomes of acute myocardial infarction‐cardiogenic shock patients receiving percutaneous left ventricular support
  Catheterization and Cardiovascular Interventions, 2023
• Use of Tissue Plasminogen Activator Alteplase for Suspected Impella Thrombosis
  Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2019
• Minimally Invasive Biventricular Mechanical Circulatory Support with Impella Pumps as a Bridge to Heart Transplantation: A First-in-the-World Case Report
  ESC Heart Failure, 2019
• Full Percutaneous Biventricular Support with Two Impella Pumps: The Bi-Pella Approach
  ESC Heart Failure, 2018
• Activated Clotting Time (ACT)
  2013
• Antifactor Xa Levels versus Activated Partial Thromboplastin Time for Monitoring Unfractionated Heparin
  Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2012
• Heparinresistenz und Antithrombinmangel*
  Medizinische Klinik, 2009
• Long-term Efficacy of Bivalirudin and Provisional Glycoprotein IIb/IIIa Blockade vs Heparin and Planned Glycoprotein IIb/IIIa Blockade During Percutaneous Coronary RevascularizationREPLACE-2 Randomized Trial
  JAMA, 2004
• Bivalirudin and Provisional Glycoprotein IIb/IIIa Blockade Compared With Heparin and Planned Glycoprotein IIb/IIIa Blockade During Percutaneous Coronary Intervention
  JAMA, 2003
• Heparin elimination following continuous infusion during intra‐aortic balloon counterpulsation
  Catheterization and Cardiovascular Diagnosis, 1985